The new test could signal whether treatment is working months earlier than standard imaging scans, allowing doctors to try alternatives sooner, initial results show.
Head and Neck Cancer
Vaccines and other policies could help keep in check a disease that’s becoming increasingly common worldwide.
This phase 2 trial also identified a subset of patients with specific mutations who may see the most benefit from the drug.
When the surgical wound doesn’t heal right, it can send some patients back to the operating room.
Researchers find infiltrating lymphocytes tie to survival in patients with recurrent larynx cancer; findings suggest super-boosting the immune system before additional treatment.